Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: GMP violations

The Role of TGA GMP in Ensuring the Integrity of Pharmaceutical Products in Australia

Posted on January 1, 2025 By digi

The Role of TGA GMP in Ensuring the Integrity of Pharmaceutical Products in Australia How TGA GMP Safeguards the Integrity of Pharmaceutical Products Introduction to TGA GMP and Product Integrity The Therapeutic Goods Administration (TGA) enforces Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of pharmaceutical products in Australia. A cornerstone of…

Read More “The Role of TGA GMP in Ensuring the Integrity of Pharmaceutical Products in Australia” »

TGA GMP Guidelines

The Future of MHRA GMP Regulations and Their Impact on Pharma Manufacturing

Posted on January 1, 2025 By digi

The Future of MHRA GMP Regulations and Their Impact on Pharma Manufacturing What Lies Ahead: The Future of MHRA GMP Regulations and Their Impact on Pharma Manufacturing Introduction to Evolving MHRA GMP Regulations The pharmaceutical industry is undergoing rapid transformation driven by advancements in technology, evolving patient needs, and increasing regulatory scrutiny. The Medicines and…

Read More “The Future of MHRA GMP Regulations and Their Impact on Pharma Manufacturing” »

MHRA GMP Guidelines

How to Address Non-Conformities Identified During NMPA GMP Inspections

Posted on January 1, 2025 By digi

How to Address Non-Conformities Identified During NMPA GMP Inspections How to Address Non-Conformities Identified During NMPA GMP Inspections Introduction to NMPA GMP Inspections Ensuring compliance with Good Manufacturing Practices (GMP) is a key aspect of the pharmaceutical industry’s responsibility to maintain product quality, safety, and efficacy. In China, the National Medical Products Administration (NMPA), formerly…

Read More “How to Address Non-Conformities Identified During NMPA GMP Inspections” »

NMPA GMP Guidelines

How WHO GMP Guidelines Impact the Production of Vaccines

Posted on January 1, 2025 By digi

How WHO GMP Guidelines Impact the Production of Vaccines The Role of WHO GMP Guidelines in Ensuring Vaccine Quality and Safety Introduction to WHO GMP and Vaccine Production Vaccines are a cornerstone of global health, preventing the spread of infectious diseases and saving millions of lives annually. The complexity of vaccine production, however, demands rigorous…

Read More “How WHO GMP Guidelines Impact the Production of Vaccines” »

WHO GMP Guidelines

The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance

Posted on December 31, 2024 By digi

The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance Introduction to Regulatory Harmonization and Its Importance Regulatory harmonization refers to the process of aligning the regulatory requirements of different countries or regions to ensure consistency, mutual recognition, and efficiency in regulatory practices….

Read More “The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance” »

GMP in Latin America (ANVISA, COFEPRIS)

Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing

Posted on December 31, 2024 By digi

Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing Leveraging Technology to Comply with Schedule M (Revised) GMP in Pharmaceutical Manufacturing Introduction to Technology in Pharmaceutical GMP Pharmaceutical manufacturing has evolved significantly with advancements in technology. As regulations become more stringent, technology plays an indispensable role in ensuring compliance with Good Manufacturing…

Read More “Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing” »

SCHEDULE - M - Revised

How to Align TGA GMP with Other International Drug Regulatory Guidelines

Posted on December 31, 2024 By digi

How to Align TGA GMP with Other International Drug Regulatory Guidelines Strategies for Aligning TGA GMP with Global Pharmaceutical Regulatory Standards Introduction to TGA GMP and International Standards Pharmaceutical manufacturing is a global industry, with products often crossing borders before reaching consumers. The Therapeutic Goods Administration (TGA) enforces Good Manufacturing Practices (GMP) in Australia to…

Read More “How to Align TGA GMP with Other International Drug Regulatory Guidelines” »

TGA GMP Guidelines

How to Address Non-Conformities Identified During PMDA GMP Inspections

Posted on December 31, 2024 By digi

How to Address Non-Conformities Identified During PMDA GMP Inspections How to Address Non-Conformities Identified During PMDA GMP Inspections Introduction to PMDA GMP Inspections The Pharmaceutical and Medical Devices Agency (PMDA) enforces Good Manufacturing Practices (GMP) in Japan to ensure that pharmaceutical products are consistently produced and controlled according to high standards of safety, efficacy, and…

Read More “How to Address Non-Conformities Identified During PMDA GMP Inspections” »

PMDA GMP Guidelines

How WHO GMP Guidelines Help Pharmaceutical Companies Achieve Global Market Access

Posted on December 31, 2024 By digi

How WHO GMP Guidelines Help Pharmaceutical Companies Achieve Global Market Access Achieving Global Market Access Through WHO GMP Compliance Introduction to WHO GMP and Global Market Access Pharmaceutical companies aiming to expand their presence in international markets must meet stringent regulatory requirements to ensure the safety, quality, and efficacy of their products. The World Health…

Read More “How WHO GMP Guidelines Help Pharmaceutical Companies Achieve Global Market Access” »

WHO GMP Guidelines

How to Implement Continuous Improvement for MHRA GMP Compliance

Posted on December 31, 2024 By digi

How to Implement Continuous Improvement for MHRA GMP Compliance Continuous Improvement Strategies for MHRA GMP Compliance Introduction to Continuous Improvement and MHRA GMP Continuous improvement is a fundamental concept in maintaining compliance with the Medicines and Healthcare products Regulatory Agency (MHRA) Good Manufacturing Practices (GMP). As regulatory requirements evolve and new challenges emerge, pharmaceutical companies…

Read More “How to Implement Continuous Improvement for MHRA GMP Compliance” »

MHRA GMP Guidelines

Posts pagination

Previous 1 … 14 15 16 … 50 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog

GMP violations

  • How to Meet Health Canada GMP Requirements for Pharmaceutical Packaging and Distribution
  • Health Canada GMP Compliance and Its Impact on Global Pharma Manufacturing
  • How FDA GMP Guidelines Shape the Future of Pharmaceutical Manufacturing
  • How Health Canada GMP Regulations Promote Drug Safety and Efficacy
  • Best Practices for Preparing for FDA GMP Inspections in Pharmaceutical Facilities
  • How Health Canada GMP Helps with Regulatory Inspections in Canada
  • How to Use FDA GMP Compliance to Improve Operational Efficiency
  • How Health Canada GMP Helps with Regulatory Inspections in Canada
  • How FDA GMP Regulations Address Packaging and Labeling Compliance
  • How Health Canada GMP Standards Support Pharmaceutical Product Development

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme